Ardelyx reported $-27807000 in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Abbott ABT:US $ 2478M 434M
Amgen AMGN:US $ 2176M 324M
Astrazeneca AZN:US 2.2B 673M
Biocept BIOC:US $ -2707000 68.54K
Chimerix CMRX:US -24771000 14.76M
Corcept Therapeutics CORT:US $ 31.43M 4.66M
Curis CRIS:US $ -15061000 72K
Life Technologies LIFE:US $ -12378000 3.74M
Opko Health OPK:US $ -26104000 46.32M
Tg Therapeutics TGTX:US $ -66872000 26.08M
United Therapeutics UTHR:US $ 201.8M 86.2M
Xoma XOMA:US $ -4767000 2.7M